Australian Vintage Ltd (AVG)
Australian Securities Exchange · Australia · prices in AUD · close of 19 Oct 2026
Key indicators
| Last close | AUD 0.092 |
|---|---|
| 52-week range | 0.050 – 0.130 |
| Return, 1 month / 3 months | +13.6% / +37.3% |
| Return, 1 year / 3 years | −23.3% / −77.6% |
| Trend | Uptrend |
| RSI (14) | 64 |
| Volatility (1 year) | 59.9% |
| Worst drawdown (1 year) | -57.7% |
| Average daily value traded | 0.01M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Australian Vintage is a wine company based in Australia. It makes and markets wine under several brands, including McGuigan and Tempus Two, and produces a range of still and sparkling wines. The company runs vineyards and wineries in Australian wine regions and sells its products to retailers, distributors and hospitality customers in its home market and in overseas markets such as the United Kingdom. Its business covers grape growing, winemaking, bottling and the marketing of branded wine.
On this site Australian Vintage Ltd appears as a stock on the Australian Securities Exchange (Australia), code AVG, with prices in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Australian Vintage Ltd (AVG) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.092 on 19 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 614 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 23.3% and over the last three months it rose 37.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 78 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 17.7% | ||
| From 52-week high | -29.2% | ||
| Momentum | 74 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 37.3% | ||
| 6-month return | 24.3% | ||
| 12-month return, skipping the last month | -32.5% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 59.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -57.7% | ||
| Liquidity | 28 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.2% |
|---|---|
| 1 month | +13.6% |
| 3 months | +37.3% |
| 6 months | +24.3% |
| 1 year | −23.3% |
| 3 years | −77.6% |
| 5 years | −88.5% |
Signals
| 50-day / 200-day average | 0.081 / 0.078 |
|---|---|
| Golden / death cross (60 days) | Golden, 4 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.003 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Nov 2022 | AUD 0.0308 |
| 25 Nov 2021 | AUD 0.0245 |
| 5 Jul 2021 | AUD 0.0694 |
| 15 Oct 2020 | AUD 0.0245 |
| 17 Oct 2019 | AUD 0.0181 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.